Related Experiment Video
Updated: Dec 14, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
A brand-new cardiorenal syndrome in the COVID-19 setting
Mugurel Apetrii1,2, Stefana Enache3, Dimitrie Siriopol1,2
1Nephrology Clinic, Dialysis and Renal Transplant Center, "C.I. PARHON" University Hospital, Iasi, Romania.
Insights
Coronaviruses, including COVID-19, can affect the heart and kidneys, not just the lungs. The virus uses the ACE2 receptor, which is present in the heart, to cause cardiovascular issues.
Area of Science:
- Virology
- Cardiology
- Infectious Diseases
Background:
- Coronaviruses are significant pathogens causing respiratory infections in adults.
- The COVID-19 pandemic, caused by SARS-CoV-2, primarily affects the lungs.
- Emerging data link SARS-CoV-2 to cardiovascular complications.
Purpose of the Study:
- To investigate the link between coronavirus infections and cardiovascular system impact.
- To understand the role of ACE2 in SARS-CoV-2-related cardiovascular manifestations.
Main Methods:
- Review of existing literature on coronaviruses and COVID-19.
- Analysis of studies documenting SARS-CoV-2 interactions with ACE2.
- Examination of reported cardiovascular and renal complications in COVID-19 patients.
Main Results:
- Coronaviruses cause significant respiratory tract infections in adults.
- COVID-19 has been associated with myocarditis, myocardial infarction, heart failure exacerbation, and acute kidney injury.
- SARS-CoV-2 utilizes the ACE2 receptor for cellular entry, and ACE2 is expressed in cardiac tissue.
Conclusions:
- Coronaviruses, particularly SARS-CoV-2, pose a threat beyond the respiratory system, affecting the cardiovascular system.
- The expression of ACE2 in the heart provides a molecular mechanism for viral-induced cardiac pathology.
- Further research is warranted to fully elucidate the cardiovascular sequelae of COVID-19.
Abstract:
Coronaviruses are a major pathogen for adults, causing up to one-third of community-acquired respiratory tract infections in adults during epidemics. Although the pandemic outbreak of coronavirus disease-2019 (COVID-19) targets preferentially patient's lungs, recent data have documented that COVID-19 causes myocarditis, acute myocardial infarction, exacerbation of heart failure and acute kidney injury. Studies show that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), similar to its predecessor SARS-CoV, engages angiotensin-converting enzyme 2 (ACE2) as the entry receptor. ACE2 is also expressed in the heart, providing a link between coronaviruses and the cardiovascular system.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiac Catheterization I: Pre-Procedure Overview
Cardiomyopathy VI: Nursing Management

